Gilead (NASDAQ:GILD) reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $1.3 on revenue of $5.88B. Analysts polled by anticipated EPS of $1.67 on revenue of $5.71B. That with comparison to EPS of $1.44 on revenue of $5.8B in the same period a year before. Gilead had reported EPS of $1.75 on revenue of $5.6B in the previous quarter. Analysts are expecting EPS of $1.73 and revenue of $5.56B in the upcoming quarter.
Gilead shares are up 3.79% from the beginning of the year , still down 4.01% from its 52 week high of $70.26 set on February 4, 2019. They are under-performing the NASDAQ 100 which is up 6.04% year to date.
Gilead shares lost 1.82% in after-hours trade after the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on January 29 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
